HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway
2018 · Cell Death and Disease · 274 citations
https://doi.org/10.1038/s41419-018-0534-9
Y
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
30
Papers
849
Citations
15
h-index
16
i10-index
Yuchao He is an academic researcher from Tianjin Medical University Cancer Institute and Hospital. The author has contributed to research in topics: RNA modifications and cancer & Cancer-related molecular mechanisms research & MicroRNA in disease regulation. The author has an h-index of 15, co-authored 26 publications.
ORCID: 0000-0001-5264-3700Papers by this author
worksLDLR inhibition promotes hepatocellular carcinoma proliferation and metastasis by elevating intracellular cholesterol synthesis through the MEK/ERK signaling pathway
2021 · Molecular Metabolism · 73 citations
https://doi.org/10.1016/j.molmet.2021.101230
PNO1 inhibits autophagy-mediated ferroptosis by GSH metabolic reprogramming in hepatocellular carcinoma
2022 · Cell Death and Disease · 73 citations
https://doi.org/10.1038/s41419-022-05448-7
PNO1 regulates autophagy and apoptosis of hepatocellular carcinoma via the MAPK signaling pathway
2021 · Cell Death and Disease · 49 citations
https://doi.org/10.1038/s41419-021-03837-y
PNO1, which is negatively regulated by miR-340-5p, promotes lung adenocarcinoma progression through Notch signaling pathway
2020 · Oncogenesis · 41 citations
https://doi.org/10.1038/s41389-020-0241-0
The Combination of R848 with Sorafenib Enhances Antitumor Effects by Reprogramming the Tumor Immune Microenvironment and Facilitating Vascular Normalization in Hepatocellular Carcinoma
2023 · Advanced Science · 34 citations
https://doi.org/10.1002/advs.202207650
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat